Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02505919 · ClinicalTrials.gov registry record · NA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A NA study, sponsored by PROCEPT BioRobotics.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
NCT02505919: Completed NA study, sponsored by PROCEPT BioRobotics.
NCT02505919 is a NA study that has completed, run by PROCEPT BioRobotics. The registered enrollment target is 184 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02505919, a NA study, has completed, sponsored by PROCEPT BioRobotics.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
Study Summary
A prospective multicenter randomized blinded study comparing Aquablation of the prostate with the AQUABEAM System and TURP for the treatment of Lower Urinary Tract Symptoms (LUTS). The primary endpoints for safety and effectiveness were measured at 3 and 6 months, respectively, and subjects were followed out to 5 years to collect long-term clinical data.
Primary Outcome
The primary safety endpoint is the proportion of subjects with adverse events rated as probably or definitely related to the study procedure classified as Clavien-Dindo Grade 2 or higher or any Grade 1 event resulting in persistent disability (e.g. ejaculatory disorder or erectile dysfunction) evidenced through 3 months post treatment. Note that the Clavien-Dindo classification scheme is for grading postoperative complications not events that reflect lack of effective treatment. Results are pres
Interventions
- DEVICE AQUABEAM System
- PROCEDURE Transurethral Resection of the Prostate (TURP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2015-10-30 |
| Est. Completion | 2021-12-16 |
| Phase | NA |
What the finished NCT02505919 record still lists
NCT02505919 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which AQUABEAM System is the first listed.
NCT02505919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02505919 about?
NCT02505919 is a clinical study titled "Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)". A prospective multicenter randomized blinded study comparing Aquablation of the prostate with the AQUABEAM System and TURP for the treatment of Lower Urinary Tract Symptoms (LUTS). The primary endpoints for safety and effectiveness were measured at 3 and 6 months, respectively, and subjects were fol...
What is the current status of trial NCT02505919?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2015-10-30. Estimated completion is 2021-12-16.
What interventions are being tested in trial NCT02505919?
The interventions under investigation include: AQUABEAM System (DEVICE), Transurethral Resection of the Prostate (TURP) (PROCEDURE).
Who is sponsoring clinical trial NCT02505919?
This trial is sponsored by PROCEPT BioRobotics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02505919's enrollment target sits among peer trials
184 581st of 2000 higher than 1,417 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI